Dragni Dragnev

Biotech Products Services & Research Inc. (OTCMKTS:BPSR) Gains More Ground

by Dragni Dragnev February 26, 2016

Biotech Products Services & Research Inc. (OTCMKTS:BPSR, BPSR message board) managed to climb 7% up the charts in yesterday's session, and has already added that much to its market value in today's early trading – there just seems to be no stopping the ticker now.

However, upon closer examination, a couple of huge red flags that don't really bode well for BPSR investor value inevitably stick out like sore thumb.

Like the fact that the only reason why BPSR is on the rise is a video that presents the company as the greatest thing since sliced bread.

But is it, really? Because its latest financial report doesn't really outline it as the soon-to-be top-dog of the pharmaceutical industry:

  • Cash - $127 thousand
  • Total current assets - $135 thousand
  • Total current liabilities - $483 thousand
  • Quarterly revenues - $61 thousand
  • Quarterly net loss - $362 thousand

No, in fact these numbers look rather bleak and depressing. But you know what's even more depressing? The fact that a couple of years ago, a total of 15 million shares (as adjusted for the split) were sold for $47 thousand, and the fact that said shares are still unaccounted for. This means that said shares still threaten investor value.

So what does this all mean for investors? If we had to put it in one word, it would be “RISK”. The volatility afforded BPSR by a half million dollar paid pump could indeed create opportunities for profitable trading, but investors need to be aware that things could turn very ugly very quickly, and that with each day that passes the odds become worse, not better.

With this in mind, let the buyer beware.

Comments 0

Type the characters that you see in the box (5 characters).